Equine platelet CD62P (P-selectin) expression: A phenotypic and morphologic study

Veterinary Immunology and Immunopathology

Volumn 91, Issue 2, 2003, Pages 119-134

  Lalko, Cory C ^a   Deppe, Elisabeth ^a   Ulatowski, Dan ^a   Lutgen, Amy ^a   Hart, Arlene P ^a   Patton, Elisabeth A ^a   Lunn, D Paul ^a   Suresh, M ^a   Darien, Benjamin J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Equine platelet CD62P (P selectin) and CD41 61; Flow cytometric analysis; Leukocyte CD11a CD18; Platelet leukocyte aggregates

Indexed keywords

AMIDE; FIBRIN; GLYCYLPROLYLARGINYLPROLINAMIDE; PADGEM PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD VESSEL INJURY; CELL INTERACTION; CELLULAR PARAMETERS; COLIC; CONTROLLED STUDY; ENDOTOXEMIA; FLOW CYTOMETRY; HEALTH STATUS; HORSE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; POLYMERIZATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; SURVIVAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANIMALS; ANTIBODY SPECIFICITY; BLOOD PLATELETS; FLOW CYTOMETRY; GENE EXPRESSION; HORSES; HUMANS; LEUKOCYTES; P-SELECTIN; PLATELET AGGREGATION; THROMBIN; TIME FACTORS;

EQUIDAE; EQUUS CABALLUS;

EID: 0037472546     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00287-8     Document Type: Article

References (80)

1. Abrams C.S., Ellison N., Budzynski A.Z., Shattil S.J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood. 75:1990;128-138.
2. 7. J. Leukoc. Biol. 72:2002;222-232.
3. Andrews R.K., López J.A., Berdt M.C. Molecular mechanisms of platelet adhesion and activation. Int. J. Biochem. Cell Biol. 29:1997;91-105.
4. Bailey S.R., Andrews M.J., Cunningham J.E.F. Actions and interactions of ADP, 5-HT, histamine, and PAF on equine platelets. Res. Vet. Sci. 68:2000;175-180.
5. Barton M.H., Morris D.D., Norton N., Prasse K.W. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J. Vet. Int. Med. 12:1998;26-35.
6. Blockmans D., Deckmyn H., Vermylen J. Platelet Activation. Blood Rev. 9:1995;143-156.
7. Born G.V., Dearnley R., Foulks J.G., Sharp D.E. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors. J. Physiol. 280:1978;193-212.
8. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B.C., Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8767-8771.
9. Celi A., Lorenzet R., Furie B., Furie B.C. Platelet-leukocyte-endothelial cell interaction on the blood vessel wall. Semin. Hematol. 34:1997;327-335.
10. Crockett-Torabi E. Selectins and mechanisms of signal transduction. J. Leukoc. Biol. 63:1998;1-14.
11. Cummings R.D. Structure and function of the selectin ligand PSGL-1. Braz. J. Med. Biol. Res. 32:1999;519-528.
12. Darien B.J., Potempa J., Moore J.N., Travis J. Antithrombin III activity in horses with colic: an analysis of 46 cases. Eq. Vet. J. 23:1991;211-214.
13. Darien B.J., Stone W.C., Dubielzig R.R., Clayton M.K. Morphologic changes of the ascending colon during experimental ischemia and reperfusion in ponies. Vet. Pathol. 32:1995;280-288.
14. Darien B.J., Stone W.C., Hart A.P., Schilly D.R., Clayton M.K. Systemic haemostatic alterations during no-flow ischemia and reperfusion of the ascending colon in ponies. Comp. Haematol. Int. 6:1996;63-69.
15. Dolente B.A., Wilkins P.A., Boston R.C. Clinicopathologic evidence of disseminated intravascular coagulation in horses with acute colitis. J. Am. Vet. Med. Assoc. 220:2002;1038-1043.
16. Eppihimer M.J., Schaub R.G. P-Selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler. Thromb. Vasc. Biol. 20:2000;2483-2488.
17. Escolar G., White J.G. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies. Thromb. Haemost. 83:2000;371-386.
18. Evangelista V., Manarini S., Sideri R., Rotondo S., Martelli N., Piccoli A., Totani L., Piccardoni P., Vestweber D., de Gaetano G., Cerletti C. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 93:1999;876-885.
19. Furie B., Furie B.C., Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signaling and cell adhesion. Thromb. Haemost. 86:2001;214-221.
20. Gawaz M., Fateh-Moghadam S., Pilz G., Gurland H.J., Werdan K. Platelet activation and interaction with leukocytes in patients with sepsis or multiple organ failure. Eur. J. Clin. Invest. 25:1995a;843-851.
21. Gawaz M., Fateh-Moghadam S., Pilz G., Gurland H.J., Werdan K. Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation. Infection. 23:1995b;16-23.
22. Gawaz M., Dickfield T., Bonger C., Fateh-Moghadam S., Neumann F.J. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med. 23:1997;379-385.
23. George J.N. Platelets. Lancet. 355:2000;1531-1539.
24. Geppert A., Zorn G., Karth G.D., Haumer M., Gwechenberger M., Koller-Strametz J., Heinz G., Huber K., Siostrzonek P. Soluble selectins and the systemic inflammatory response syndrome after successful cardiopulmonary resuscitation. Crit. Care Med. 28:2000;2360-2365.
25. Holmes M.B., Sobel B.E., Howard D.B., Schneider D.J. Differences between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications. Thromb. Res. 95:1999;75-82.
26. Hugo T.C. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit. Care Med. 28:2000;S9-S11.
27. Janes S.L., Wilson D.J., Cox A.D., Chironos N.A.F., Googall A.H. ADP causes partial degranulation of platelets in the absence of aggregation. Br. J. Haematol. 86:1994;568-573.
28. Jarvis G.E., Evans R.J. Endotoxin-induced platelet aggregation in heparinzed equine whole blood in vitro. Res. Vet. Sci. 57:1994;317-324.
29. Jarvis G.E., Evans R.J., Heath M.F. The role of ADP in endotoxin-induced equine platelet activation. Eur. J. Pharmacol. 315:1996;203-212.
30. Kingston J.K., Bayly W.M., Sellon D.C., Meyers K.M., Wardrop K.J. Effects of sodium citrate, low molecular weight heparin, and prostaglandin E1 on aggregation, fibrinogen binding, and enumeration of equine platelets. Am. J. Vet. Res. 62:2001;547-553.
31. Kirkpatrick U.J., Blann M.M., McCollum C.N. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thrombos. Haemost. 78:1997;1338-1342.
32. Klinger M.H.F. Platelets and inflammation. Anat. Embryol. 196:1997;1-11.
33. Kydd, J.H., Antczak, D.F., Allen, W.R., Barbis, D., Butcher, G., Davis, W., Duffus, W.P.H., Edington, N., Grunig, G., Holmes, M.A., Lunn, D.P., McCullock, J., O'Brien, M.A., Perryman, L.E., Tavernor, A.S., Williamson, S., Zhang, C., 1994. Report of the First International Workshop on Equine Leukocyte Antigens, Cambridge, UK, July 1991. Vet. Immunol. Immunopathol. 42, 1-60.
34. Lefer D.J. Pharmacology of selectin inhibitors in ischemia/reperfusion states. Ann. Rev. Pharmcacol. Toxicol. 40:2000;283-294.
35. Leithäuser B., Mattias F.R., Nicolai U., Voss R. Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Intensive Care Med. 22:1996;631-636.
36. Leytin V., Mody M., Semple J.W., Garvey B., Freedman J. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62P) expression: theoretical considerations and evaluation in thrombin-treated platelet populations. Biochem. Biophys. Res. Commun. 269:2000;85-90.
37. Li N., Goodall A.H., Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry. 35:1999;154-161.
38. Mavrommatis A.C., Theodoridis T., Orfanidou A., Roussos C., Christopoulou-Kokkinou V., Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit. Care Med. 28:2000;451-457.
39. McEver R.P., Beckstead J.H., Moore K.L., Marshall-Carlson L., Bainton D.F. GMP-140, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weible-Palade bodies. J. Clin. Invest. 84:1989;92-99.
40. McEver R.R. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann. New York Acad. Sci. 714:1994;185-189.
41. McEver R.R. Regulation of function and expression of P-selectin. Agents Actions Suppl. 47:1995;117-119.
42. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 100:1997;485-492.
43. Meyers K.M., Linder C., Grant B. Characterization of equine platelet aggregation response. Am. J. Vet. Res. 40:1979;260-264.
44. Meyers, K.M., Holmsen, H., Seachord, C.L., 1982. Comparative study of platelet dense granule constituents. Am. J. Physiol. 243 (Regulatory Integrative Comp. Physiol. 12):R454-461.
45. Michelson A.D. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coagul. Fibrinolysis. 5:1994;121-131.
46. Monreal L., Anglés A., Espada Y., Monasterio J., Monreal M. Hypercoagulation and hypofibrinolysis in horses with colic and DIC. Equine Vet. J. Suppl. 32:2000;19-25.
47. Mulligan M.S., Polley M.J., Bayer R.J., Nunn M.F., Paulson J.C., Ward P.A. Neutrophil-dependent acute lung injury: requirement for p-selectin (GMP-140). J. Clin. Invest. 90:1992;1600-1607.
48. Mulligan M.S., Watson S.R., Fennie C., Ward P.A. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J. Immunol. 151:1993;6410-6417.
49. Myers D.D. Jr., Schaub R., Wrobleski S.K., Londy F.J., Fex B.A., Chapman A.M., Greenfield L.J., Wakefield T.W. P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb. Haemost. 85:2001;423-429.
50. Nurden P. Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension. Thromb. Haemost. 78:1997;1305-1315.
51. Ogura H., Kawasaki T., Tanaka H., Koh T., Tanaka R., Ozeki Y., Hosotsubo H., Kuwagata Y., Shimazu T., Sugimoto H. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J. Trauma. 50:2001;801-809.
52. Opal S.M., Sypek J.P., Keith J.C. Jr., Schaub R.G., Palardy J.E., Parejo N.A. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection. Shock. 15:2001;285-290.
53. Palabrica T., Lobb R., Furie B.C., Aronovitz M., Benjamin C., Hsu Y., Sajer S.A., Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:1992;848-851.
54. Pintado C.O., Friend M., Llanes D. Characterization of membrane receptor on ruminants and equine platelets and peripheral blood leukocytes similar to human integrin receptor glycoprotein Iib/IIIa (CD41/61). Vet. Immunmol. Immunopathol. 44:1995;359-368.
55. Prasse K.W., Topper M.J., Moore J.N., Welles E.G. Analysis of hemostasis in horses with colic. J. Am. Vet. Med. Assoc. 203:1993;685-693.
56. Rendu F., Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets. 12:2001;261-273.
57. Ruf A., Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin. Thromb. Hemost. 21:1995;146-151.
58. Scalia R., Hayward R., Armstead V.E., Minchenko A.G., Lefer A.M. Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interaction in vivo: role in rat traumatic shock. Circ. Res. 84:1999;93-102.
59. Shattil S.J., Cunningham M., Hoxie J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 70:1987;307-315.
60. Shattil S.J., Kashiwagi H., Pampori N. Integrin signaling: the platelet paradigm. Blood. 91:1998;2645-2657.
61. Singbartl K., Green S.A., Ley K. Blocking P-selectin protects from ischemia/reperfusion induced acute renal failure. FASEB J. 14:2000;48-54.
62. Singbartl K., Forlow S.B., Ley K. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J. 15:2001;2337-2344.
63. Snyder J.R., Pascoe J.R., Olander H.J., Hinds D.M., Young R., Tyler W.S. Vascular injury associated with naturally occurring strangulation obstructions of the equine large colon. Vet. Surg. 19:1990;446-455.
64. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., Tilney N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rate kidney: inhibition by a soluble P-selectin ligand. J. Clin. Invest. 99:1997;2682-2690.
65. Tang T., Frenette P.S., Hynes R.O., Wagner D.D., Mayadas T.N. Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J. Clin. Invest. 97:1996;2485-2490.
66. Tapper H., Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood. 96:2000;2329-2337.
67. Theoret J.F., Bienvenu J.G., Kumar A., Merhi Y. P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. J. Pharmacol. Exp. Ther. 298:2001;658-664.
68. Topper M.J., Prasse K.W. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic. Am. J. Vet. Res. 57:1996;456-462.
69. Weiss D.J., McClay C.B., Smith C.M., Rao G.H.R., White J.G. Platelet function in the racing thoroughbred: implication for exercise-induced pulmonary hemorrhage. Vet. Clin. Path. 19:1990;35-39.
70. Weiss D.J., Evanson O.A. Detection of activated platelets and platelet-leukocyte aggregates in horses. Am. J. Vet. Res. 58:1997;823-827.
71. Weiss D.G., Evanson O.A., Wells R.E. Evaluation of argenine-glycine-aspartate-containing peptides as inhibitors of equine platelet function. Am. J. Vet. Res. 58:1997;457-460.
72. Weiss D.J., Rashid J. The sepsis-coagulant axis: a review. J. Vet. Intern. Med. 12:1998;317-324.
73. Weiss D.J., Evanson O.A., McClenahan D., Fagliari J., Walcheck B. Shear-induced platelet activation and platelet-neutrophil aggregate formation by equine platelets. Am. J. Vet. Res. 59:1998a;1243-1246.
74. Weiss D.J., Evanson O.A., Fagliari J.J., Valberg S. Evaluation of platelet activation and platelet-neutrophil aggregates in Thoroughbreds undergoing near-maximal treadmill exercise. Am. J. Vet. Res. 59:1998b;393-396.
75. Welch R.D., Watkins J.P., Taylor T.S., Cohen N.D., Carter G.K. Disseminated intravascular coagulation associated with colic in 23 horses (1984-1989). J. Vet. Intern. Med. 6:1992;29-35.
76. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., Prescott S.M., Zimmerman G.A. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest. 97:1996;1525-1534.
77. Winn R.K., Liggitt D., Vedder N.B., Paulson J.C., Harlan J.M. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J. Clin. Invest. 92:1993;2042-2047.
78. Wu K.K., Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Ann. Rev. Med. 47:1996;315-331.
79. Yang J., Furie B., Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb. Haemost. 81:1999;1-7.
80. Zhang C.H., Davis W.C., Grunig G., Antzak D.F. The equine homologue of LFA-1 (CD11a/CD18): cellular distribution and differential determinants. Vet. Immunol. Immunopathol. 62:1998;167-183.